Você procurou por: patsiendirühmadel (Estoniano - Inglês)

andmed erinevatel patsiendirühmadel
special populations

andmed erinevatel patsiendirühmadel:
adult patients

seda kasutatakse järgmistel patsiendirühmadel.
it is used to treat the following groups:

seda kasutatakse järgmistel patsiendirühmadel:
it is used in the following groups:

ovaleapi kasutatakse järgmistel patsiendirühmadel:
it is used to treat the following groups:

ravimit ei tohi kasutada järgmistel patsiendirühmadel:
abseamed must not be used in the following groups:

entyvio kasutamist neil patsiendirühmadel ei ole uuritud.
entyvio has not been studied in these patient populations.

nendel patsiendirühmadel ei ole simponi kasutamist uuritud.
simponi has not been studied in these patient populations.

ravimit gonal-f kasutatakse järgmistel patsiendirühmadel:
gonal-f is used to treat the following groups:

exjadet kasutatakse kroonilise raualiigsuse raviks järgmistel patsiendirühmadel:
exjade is used to treat chronic iron overload (an excess of iron in the body) in the following groups of patients:

et levitrat ei ole uuritud järgmistel patsiendirühmadel, ei tohi seda kasutada:
because levitra has not been studied in the following group patients, they must not use the medicine:

velcadet kasutatakse hulgimüeloomi (teatud verevähk) raviks järgmistel patsiendirühmadel.
velcade is used to treat multiple myeloma, a blood cancer, in the following groups of patients:

temomedaci kasutatakse pahaloomulise glioomi (teatud ajukasvaja) ravimiseks järgmistel patsiendirühmadel.
temomedac is used to treat malignant glioma (brain tumours) in the following groups of patients:

järgmistel patsiendirühmadel on pradaxa soovituslik ööpäevane annus 150 mg, võttes kaks 75 mg kapslit korraga.
for the following groups the recommended daily dose of pradaxa is 150 mg taken once daily as 2 capsules of 75 mg.

clopidogrel ratiopharmi tohib kasutada järgmistel patsiendirühmadel: patsiendid, kellel on hiljuti olnud südameinfarkt.
clopidogrel ratiopharm can be given to the following groups of patients: patients who have recently had a myocardial infarction (heart attack).

järgmistel patsiendirühmadel on soovitatav pradaxa ööpäevane annus 220 mg, manustades üks 110 mg kapsel kaks korda ööpäevas:
for the following groups the recommended daily dose of pradaxa is 220 mg taken as one 110 mg capsule twice daily:

clopidogrel ratiopharm gmbh-d tohib kasutada järgmistel patsiendirühmadel: patsiendid, kellel on hiljuti olnud südameinfarkt.
clopidogrel ratiopharm gmbh can be given to the following groups of patients: patients who have recently had a myocardial infarction (heart attack).

trulicity’t ei soovitata lastele ja alla 18-aastastele noorukitele, sest selle kasutamist ei ole neil patsiendirühmadel uuritud.
trulicity is not recommended for children and adolescents under 18 years of age because it has not been studied in these patients.

clopidogrel ratiopharmi tohib kasutada järgmistel patsiendirühmadel: patsiendid, kellel on hiljuti olnud müokardiinfarkt (südameinfarkt).
clopidogrel ratiopharm can be given to the following groups of patients: patients who have recently had a myocardial infarction (heart attack).

mõõduka ja raske maksapuudulikkusega patsientide korral on ceplene sisaldus plasmas suurem ning nendel patsiendirühmadel esineb pärast ceplene manustamist sagedamini tahhükardiat ja madalat vererõhku kui normaalse maksatalitluse või kerge maksapuudulikkusega patsientidel.
plasma ceplene levels are higher in patients with moderate and severe liver impairment, and these patient groups tend to experience more tachycardia and lower blood pressure after ceplene dosing than do patients with normal or mildly affected liver function.